MedTrace Logo

Alpha-lipoic Acid Combined With B Vitamins Shows Promise for Treating Restless Legs Syndrome

NCT06324760 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2024-03-22

No results posted yet for this study

Summary

Investigating Tiobec® 400's efficacy in alleviating Restless Legs Syndrome symptoms sheds light on promising therapeutic avenues.

Conditions

  • Restless Legs Syndrome

Interventions

DIETARY_SUPPLEMENT

Alpha-lipoic acid combined with B vitamins

The investigational product utilized in this research, Tiobec® 400 is a dietary supplement enriched with ALA, B vitamins, and vitamins E and C. T400 is designed to mitigate oxidative stress and support the optimal functioning of the nervous system

Sponsors & Collaborators

  • Uriach Consumer Healthcare

    lead INDUSTRY

Principal Investigators

  • Javier Albares, Doctor · Centro Medico Teknon

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-04
Primary Completion
2021-06-02
Completion
2021-06-02

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06324760 on ClinicalTrials.gov